We also noted that mutations in SMARCA4 and KEAP1 were exclusively detected in patients with classic LCC, whereas RICTOR, BRAF, ROS1 and TET2 mutations were only detected in those with LCNEC. This evidence concerns the gene KEAP1 and large cell neuroendocrine carcinoma.